SE7602871L - Vaccin for aktiv immunisering - Google Patents
Vaccin for aktiv immuniseringInfo
- Publication number
- SE7602871L SE7602871L SE7602871A SE7602871A SE7602871L SE 7602871 L SE7602871 L SE 7602871L SE 7602871 A SE7602871 A SE 7602871A SE 7602871 A SE7602871 A SE 7602871A SE 7602871 L SE7602871 L SE 7602871L
- Authority
- SE
- Sweden
- Prior art keywords
- vaccine
- hepatitis
- active immunization
- proteinaceous matter
- particle specific
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 208000002672 hepatitis B Diseases 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7508046A FR2303562A1 (fr) | 1975-03-14 | 1975-03-14 | Nouvelle preparation d'antigene utilisable comme vaccin |
US05/631,961 US4118479A (en) | 1975-03-14 | 1975-11-17 | Vaccine for active immunization containing hepatitis B surface antigen and associated antigen |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7602871L true SE7602871L (sv) | 1976-09-15 |
SE437329B SE437329B (sv) | 1985-02-25 |
Family
ID=26218778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7602871A SE437329B (sv) | 1975-03-14 | 1976-02-27 | Sett att ur blodserum framstella vaccin mot virushepatit |
Country Status (9)
Country | Link |
---|---|
US (1) | US4118478A (sv) |
JP (1) | JPS51133414A (sv) |
AT (1) | AT349136B (sv) |
AU (1) | AU505999B2 (sv) |
CA (1) | CA1066190A (sv) |
DE (1) | DE2610717C3 (sv) |
MX (1) | MX3473E (sv) |
NL (1) | NL7602621A (sv) |
SE (1) | SE437329B (sv) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4102996A (en) * | 1977-04-20 | 1978-07-25 | Merck & Co., Inc. | Method of preparing hepatitis B core antigen |
DE2750045A1 (de) * | 1977-11-09 | 1979-05-10 | Behringwerke Ag | Verfahren zur entfernung von detergentien aus virusantigensuspensionen |
ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
US4181713A (en) * | 1978-10-30 | 1980-01-01 | Merck & Co., Inc. | Isolation of HBs Ag |
US4395395A (en) * | 1979-05-21 | 1983-07-26 | The United States Of America As Represented By The Department Of Health And Human Services | Detection of non-A, non-B hepatitis associated antigen |
JPS5610119A (en) * | 1979-07-05 | 1981-02-02 | Alpha Therapeutic Corp | Manufacture of b type hepatitis infection preventive vaccine |
JPH0625069B2 (ja) * | 1981-01-29 | 1994-04-06 | ブリティッシュ・テクノロジー・グループ・リミテッド | B型肝炎ワクチン製造方法 |
DE3150935A1 (de) * | 1981-12-23 | 1983-06-30 | Uwe Dr.med. 3400 Göttingen Böttcher | Verfahren zur herstellung eines hepatitis-b impfstoffes |
US5324513A (en) * | 1984-03-07 | 1994-06-28 | Institut Pasteur | Composition useful for the fabrication of vaccines |
US4639371A (en) * | 1984-10-02 | 1987-01-27 | New York Blood Center, Inc. | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
US4683294A (en) * | 1985-04-03 | 1987-07-28 | Smith Kline Rit, S.A. | Process for the extraction and purification of proteins from culture media producing them |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4017360A (en) * | 1975-05-14 | 1977-04-12 | Merck & Co., Inc. | Method for purifying hepatitis B antigen |
US4024243A (en) * | 1975-06-16 | 1977-05-17 | Merck & Co., Inc. | Process for isolating hepatitis B antigen |
-
1976
- 1976-02-27 SE SE7602871A patent/SE437329B/sv not_active IP Right Cessation
- 1976-03-12 AU AU11967/76A patent/AU505999B2/en not_active Expired
- 1976-03-12 MX MX000071U patent/MX3473E/es unknown
- 1976-03-12 NL NL7602621A patent/NL7602621A/xx not_active Application Discontinuation
- 1976-03-12 CA CA248,345A patent/CA1066190A/en not_active Expired
- 1976-03-13 DE DE2610717A patent/DE2610717C3/de not_active Expired
- 1976-03-15 AT AT186276A patent/AT349136B/de not_active IP Right Cessation
- 1976-03-15 JP JP51028011A patent/JPS51133414A/ja active Pending
-
1977
- 1977-02-24 US US05/771,728 patent/US4118478A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1066190A (en) | 1979-11-13 |
JPS51133414A (en) | 1976-11-19 |
MX3473E (es) | 1980-12-10 |
ATA186276A (de) | 1978-08-15 |
US4118478A (en) | 1978-10-03 |
DE2610717C3 (de) | 1981-02-05 |
SE437329B (sv) | 1985-02-25 |
AT349136B (de) | 1979-03-26 |
DE2610717B2 (de) | 1980-05-14 |
DE2610717A1 (de) | 1977-05-26 |
AU1196776A (en) | 1977-09-15 |
AU505999B2 (en) | 1979-12-13 |
NL7602621A (nl) | 1976-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900001382A (ko) | 연속 셀라인에서의 ibdv생성 | |
SE7602871L (sv) | Vaccin for aktiv immunisering | |
DE3268361D1 (en) | New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process | |
ES533111A0 (es) | Un metodo de preparar una vacuna viva | |
ES467557A1 (es) | Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos. | |
SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
ATE149569T1 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
ES449941A1 (es) | Un metodo de preparacion de un nuevo virus vivo de la rabia. | |
AU530195B2 (en) | Vaccine for active immunization containing hepatitis b surface and/or e -antigens | |
FI890603A0 (sv) | Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp | |
NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
GB1016586A (en) | Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis | |
GB1518582A (en) | Viral hepatitis vaccine | |
JPS51118825A (en) | A process for preparing heat stable iga and igm | |
RO76563A2 (ro) | Procedeu de stabilizare a unui vaccin antiherpetic | |
US3255081A (en) | Anti-viral vaccines immunized against oncogenic viruses | |
IL28696A (en) | Attenuated live rubella virus vaccine and method of production | |
GB1437006A (en) | Antidistemper and anti-hepatitis vaccines | |
IE853109L (en) | Vaccines against avian infectious bronchitis | |
Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. | |
FR2262511A1 (en) | Vaccine against gosling hepatitis - prepd. from virus obtd. from liver or spleen of infected birds and grown in duckling or gosling embryo cells | |
Salmi | Purification of a soluble gel precipitating antigen of rubella virus and antibody responses to the purified antigen | |
IL61278A (en) | Process for preparing specific antigen vaccine for transmissible gastroenteritis(tge)in swine | |
DE3475309D1 (en) | Synthetic peptide, immune globulin and process for immunizing a mammal | |
SU502583A1 (ru) | Способ получения антигенного материала из лапинизированного вируса ящура |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7602871-1 Effective date: 19880125 Format of ref document f/p: F |